What is Generate Biomedicines, Inc. 's PP&E (net)?

Generate Biomedicines, Inc. (GENB) reported PP&E (net) of $27.84M in Q1 2026.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Generate Biomedicines, Inc. GENB PP&E (Net)

PP&E (Net) at other companies

ServisFirst BancsharesSFBS

$62.06M+4.4%

Evolution Metals & Technologies Corp. EMAT

$7.44M—

SeaboardSEB

$2.87B+11.1%

Liberty GlobalLBTYB

$5.32B+15.9%

SpireSR

$557.1M-2.9%

FTI ConsultingFCN

$166.21M+2.5%

Other financials

Income statement

See full

Revenue$7.2M-18.1%

Operating income-$64.1M-33.1%

Net income-$61.4M-47.4%

EPS (diluted)-$1.07+34.0%

Balance sheet

See full

Cash & equivalents$160.6M-27.2%

Total debt$65.6M—

Total equity$514.8M+209%

Total assets$625.7M—

Cash flow

See full

Operating cash flow-$80.4M-51.2%

CapEx$3.8M+403%

Free cash flow-$84.2M-56.1%

Valuation

See full

Market cap$1.86B—

Enterprise value$1.76B—

Returns & leverage

See full

Debt / equity0.1×—

Current ratio9.2×—

Where this comes from

Reported directly by Generate Biomedicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Generate Biomedicines, Inc. 's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Generate Biomedicines, Inc. 's PP&E (net)?: Generate Biomedicines, Inc. (GENB) reported PP&E (net) of $27.84M in Q1 2026.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.